arrow_back Back to App

Increased Transparency for Biologic Drugs: Availability and Information.

New rules aim to increase transparency regarding the availability of biologic drugs on the market. Pharmaceutical companies will need to report more promptly whether their products are available for sale, making it easier for citizens and doctors to access up-to-date drug information.
Key points
Companies must report the marketing status of biologic products, including those discontinued or never available for sale.
Information on biologic drug availability will be regularly updated in public lists.
Increased transparency will help in better treatment planning and access to necessary products.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_4302
Sponsor: Sen. Kaine, Tim [D-VA]
Process start date: 2022-05-25
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Biologics Market Transparency Act of 2022

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_4302.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2022-05-25.

What are the main provisions?

Key points include:

  • Companies must report the marketing status of biologic products, including those discontinued or never available for sale.
  • Information on biologic drug availability will be regularly updated in public lists.
  • Increased transparency will help in better treatment planning and access to necessary products.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Kaine, Tim [D-VA].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health